Clinical Trial Update: Efficacy and Safety of Chungkookjang on Improvement of Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial evaluating Chungkookjang for metabolic syndrome has completed Phase 2 and Phase 3 studies assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Chungkookjang

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED